Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Journal of Viral Hepatitis|November 20, 2020
Provider-related barriers and enablers to the provision of hepatitis C treatment by general practitioners in Scotland: A behaviour change analysisDavid Whiteley, Elizabeth Speakman, Lawrie Elliott, et al.Health & Social Care in the Community|July 18, 2019
Does older adults' use of social care influence their healthcare utilisation? A systematic review of international evidenceGemma Spiers, Fiona E Matthews, Suzanne Moffatt, et al.Frontline Gastroenterology|October 19, 2023
Exploring changing attitudes to non-invasive liver fibrosis tests in secondary care pathways: comparison of two national surveysKushala W M Abeysekera, Ankur Srivastava, Ian Rowe, et al.Global Health, Science and Practice|December 22, 2023
Prevalence of Skeletal Fluorosis in Northern Tanzania: A Follow-Up StudyAnna Foat, Claire Stevens, Grace George, et al.BMJ Open Gastroenterology|February 8, 2023
Stratification Of LIver Disease (SOLID): protocol for a prospective observational cohort study to determine the optimum biomarker strategies for the detection of advanced liver disease at the primary-secondary care interfaceStuart McPherson, Helen Jarvis, John McGonigle, et al.The Lancet. Gastroenterology & Hepatology|March 1, 2024
Progress is impossible without change: understanding the evolving nomenclature of steatotic liver disease and its effect on hepatology practicePaul N Brennan, Oliver D Tavabie, Wenhao Li, et al.The Lancet. Gastroenterology & Hepatology|July 1, 2026
The role of primary care in response to the global liver disease syndemic: a Lancet Gastroenterology & Hepatology CommissionHelen Jarvis, Paul N Brennan, Teresa Casanovas, et al.The Lancet Regional Health. Europe|June 10, 2026
Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver diseaseNicola Pugliese, Trenton M White, Paul N Brennan, et al.The Lancet. Gastroenterology & Hepatology|May 1, 2022
Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest GroupStuart McPherson, Matthew J Armstrong, Jeremy F Cobbold, et al.Lancet (London, England)|December 4, 2019
Unacceptable failures: the final report of the Lancet Commission into liver disease in the UKRoger Williams, Guruprasad Aithal, Graeme J Alexander, et al.Pageof 3